Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS.
Consensus statement on the treatment of multiple sclerosis by the Spanish Society of Neurology in 2016.
Relationship between disease-modifying therapy and depression in multiple sclerosis.
Multiple sclerosis: pathogenesis and treatment.
Randomized study combining interferon & glatiramer acetate in multiple sclerosis.
[Pharmacoeconomic analysis of the efficacy of natalizumab in relapsing-remitting multiple sclerosis].
Breastfeeding and multiple sclerosis relapses: a meta-analysis.
The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosis.
Effirma, Synthetic Biologics
Extraocular Source of Oligodendrocytes Contribute to Retinal Myelination and Optokinetic Responses in Zebrafish.
Paucity and Inconsistency: A Systematic Review and Critique of Budget Impact Analyses of Disease-Modifying Therapies for Multiple Sclerosis in the UK and the Implications for Policy in the UK.
Neuroprotective effects of resident microglia following acute brain injury.
Dimethyl Fumarate Protects Neural Stem/Progenitor Cells and Neurons from Oxidative Damage through Nrf2-ERK1/2 MAPK Pathway.
Regulation of brain endothelial barrier function by microRNAs in health and neuroinflammation.
Primary results of DECIDE: a randomized, double-blind, double-dummy, active-controlled trial of daclizumab HYP vs. Interferon β-1a in RRMS patients
Social Media Representation of Chronic Cerebrospinal Venous Insufficiency Intervention for Multiple Sclerosis.
The differential diagnosis of neurological diseases by fractionating electrophoretically the CSF gamma-globulins.
JC polyomavirus mutants escape antibody-mediated neutralization.
17 beta-estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis.
Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci.
Multiple sclerosis prevalence in the United States commercially insured population.
Predictors of Fatigue Impact in Persons With Long-Standing Multiple Sclerosis.
Masitinib in Patients with Primary Progressive Multiple Sclerosis (PPMS) or Relapse-Free Secondary Multiple Sclerosis (SPMS)
Pharmacokinetics and metabolism of mitoxantrone. A review.
Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus.

Pages